Search Results
ASCO 2023 Highlights on Lymphoma with Dr Edward Cliff
Updates in Lymphomas: 2023 Best of Hematology
The role of venetoclax in R/R MCL & options for patients who progress on venetoclax
The benefits of CAR-T therapy in 2L over 3L in R/R DLBCL
Relapsed/Refractory Mantle Cell Lymphoma
ASH 2019 Interview - Prof Andrew Evens - HoLISTIC Hodgkin Lymphoma International Study
November 22, 2021 Hematology/Oncology VMR wit Dr. Anand Patel - epistaxis
